Epclusa (sofosbuvir and velpatasvir)
How can I get assistance paying for Epclusa? Is Epclusa covered by insurance?
UPDATE: In 2019 Gilead, the developer of Epclusa, authorized a generic version of Epclusa.
Gilead created a Support Path™ to provide assistance to patients who are uninsured, underinsured or need financial assistance to pay for Epclusa. For more information visit www.mysupportpath.com.
Additionally, Gilead is providing a co-pay coupon to pay no more than $5 per co-pay for those that are eligible. For more details and to register visit https://www.epclusainfo.com/co-pay-coupon-registration.
Contact your insurance company directly for information regarding coverage of Epclusa.
Last Updated: January 2019
"Co-pay Coupon | EPCLUSA®." Gilead.com. Gilead Sciences, Inc., https://www.epclusainfo.com/co-pay-coupon-registration. Retrieved June 29, 2016
"Highlights of Prescribing Information." FDA.gov. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf. Retrieved June 29, 2016.
"Support Path Harvoni® and Epclusa® Tablets Treatment Support." Gilead.com. Gilead Sciences, Inc., http://www.mysupportpath.com/. Retrieved June 29, 2016.
"U.S. Food and Drug Administration Approves Gilead's Epclusa (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C. Gilead.com". http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&. Retrieved June 29, 2016.